Related Experiment Video
Updated: Jul 15, 2026

Histological Analyses of Acute Alcoholic Liver Injury in Zebrafish
Published on: May 25, 2017
Chronic effects of celecoxib, a cyclooxygenase-2 inhibitor, cause enhanced alcohol-induced liver steatosis in rats
I L Bykov1, M Palmen, K D Rainsford
1Department of Mental Health and Alcohol Research, Alcohol Research Center, National Public Health Institute, POB 33, 00251 Helsinki, Finland.
Background:
The pathogenetic role of prostaglandins in steatosis, the first stage of alcoholic liver injury, is not well understood, especially that involving the inflammatory reactions controlled by prostaglandins and pro-inflammatory cytokines in the liver. We, therefore, studied the chronic effects of the COX-2 inhibitor, celecoxib, given to ethanol-treated rats.
Methods:
Rats were fed ethanol and a low dose of celecoxib (approximately 20 mg/kg daily) in a high-fat/low-carbohydrate liquid diet for six weeks.
Results:
Ethanol treatment caused liver steatosis, moderate cellular infiltration and enhanced levels of plasma alanine transaminase (ALT) and tumour necrosis factor-alpha (TNF-alpha). Co-administration of celecoxib further increased the steatosis, relative liver weights and increased plasma ALT and TNF-alpha levels above those in ethanol-treated rats. Also, celecoxib counteracted the ethanol-induced increase in hepatic prostaglandin E(2) receptor EP4 mRNA expression. In contrast, celecoxib alone increased plasma ALT and TNF-alpha levels.
Conclusions:
These results suggest that prolonged low-dose celecoxib treatment with ethanol enhances alcohol-induced steatosis and liver inflammatory reactions above that from ethanol or celecoxib alone. It is suggested that reduction in PGE(2) by treatment with celecoxib removes the endogenous protective effect of this prostaglandin.
Related Concept Videos
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Gastritis II: Pathophysiology
Cirrhosis II: Pathophysiology
Chronic Pancreatitis II: Pathophysiology

